Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2009-9-1
pubmed:abstractText
Polymorphisms at loci controlling cellular processes such as cell cycle, DNA repair, and apoptosis may modulate the risk of cancer. We examined the association of two linked polymorphisms (G4C14-A4T14) at p73 and one polymorphism (309G > T) at MDM2 promoter with the risk of leukoplakia and oral cancer. The p73 and MDM2 genotypes were determined in 197 leukoplakia patients, 310 oral cancer patients and in 348 healthy control subjects. The p73 GC/AT genotype increased the risk of leukoplakia (OR = 1.6, 95% CI = 1.1-2.3) and oral cancer (OR = 2.4, 95% CI = 1.7-3.3) but the 309G > T MDM2 polymorphism independently could not modify the risk of any of the diseases. Stratification of the study population into subgroups with different tobacco habits showed that the risk of the oral cancer is not modified further for the individuals carrying p73 risk genotype. However, leukoplakia patients with smokeless tobacco habit showed increased risk with combined GC/AT and AT/AT (OR = 3.0, 95% CI = 1.3-7.0) genotypes. A combined analysis was done with our previous published data on p53 codon 72 pro/arg polymorphism. Analysis of pair wise genotype combinations revealed increase in risk for specific p73-MDM2 and p73-p53 genotype combinations. Finally, the combined three loci analyses revealed that the presence of at least one risk allele at all three loci increases the risk of both leukoplakia and oral cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1098-2744
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
48
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
790-800
pubmed:meshHeading
pubmed-meshheading:19204927-Adult, pubmed-meshheading:19204927-DNA-Binding Proteins, pubmed-meshheading:19204927-Female, pubmed-meshheading:19204927-Gene Frequency, pubmed-meshheading:19204927-Genotype, pubmed-meshheading:19204927-Humans, pubmed-meshheading:19204927-Leukoplakia, pubmed-meshheading:19204927-Linkage Disequilibrium, pubmed-meshheading:19204927-Male, pubmed-meshheading:19204927-Middle Aged, pubmed-meshheading:19204927-Mouth Neoplasms, pubmed-meshheading:19204927-Nuclear Proteins, pubmed-meshheading:19204927-Odds Ratio, pubmed-meshheading:19204927-Polymorphism, Single Nucleotide, pubmed-meshheading:19204927-Proto-Oncogene Proteins c-mdm2, pubmed-meshheading:19204927-Risk Factors, pubmed-meshheading:19204927-Smoking, pubmed-meshheading:19204927-Tobacco, Smokeless, pubmed-meshheading:19204927-Tumor Suppressor Protein p53, pubmed-meshheading:19204927-Tumor Suppressor Proteins
pubmed:year
2009
pubmed:articleTitle
Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer.
pubmed:affiliation
Molecular & Human Genetics Division, Indian Institute of Chemical Biology, Kolkata 700 032, India.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't